SCREENING AND MANAGEMENT OF ASYMPTOMATIC NEWBORNS

Slides:



Advertisements
Similar presentations
Using the Insulin Subcutaneous Order & Blood Glucose Record – Adult
Advertisements

Considerations for the Neonate Delivered at Home Susan J Dulkerian, MD Director of Nurseries, Mercy Medical Center Fetus and Newborn Subcommitee Chair.
Monitoring diabetes Diabetes Outreach (March 2011)
Introducing The SHINE Trial (Stroke Hyperglycemia Insulin Network Effort) An Overview for Clinical Nurses NIH-NINDS U01 NSO69498.
Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,
Family Centered Approach Hussain Ali Maseeh, Psy.D. Director of SEDIC.
CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.
Planned Home Birth: American Academy of Pediatrics Policy Statement Kristi Watterberg For the Committee on Fetus & Newborn.
Presented To Department of Nursing March 5, 2008 Carol Burke, APN Evidenced Based Practice Neonatal Hypoglycemia.
Newborn Screening for Critical Congenital Heart Disease
Umbilical cord clamping in term deliveries: the RCOG perspective Dr Anna David Reader and Consultant in Obstetrics and Maternal Fetal Medicine UCL Institute.
Hypoglycemia in the Newborn. Case 1 A four hour infant who was born by crash LTCS at 38 weeks for non-reassuring fetal status. The mother who used cocaine.
Maryland Patient Safety Center 3Rs: Risks, Referrals and Readmissions.
Chapter 11 Newborn Screening. Introduction Newborns can be screened for an increasing variety of conditions on the principle that early detection can.
Establishing a Successful Discharge Readiness Program in the NICU Presented by: Michelle Clements, RN WakeMed Intensive Care Nursery November 11, 2009.
©2014 MFMER | slide-1 Going Against the Grain Improving Processes Related to Patient Comorbidities Alison M. Knight, P.E. IIE 2014 National Conference.
Hospital Practices Influence Breastfeeding Rates: The Data Tell the Story Birth & Beyond California: Breastfeeding Training & QI Project With funding from.
10 Rights of Medication Administration
Sponsors for the Evening Novo Nordisk Medtronic of Canada Ltd Roche Diagnostics DiNiro Family Golf Tournament Fundraiser to the Pediatric Diabetes Clinic.
Kylia Crane, RDN, LD Nutrition Coordinator Georgia Chapter- American Academy of Pediatrics WIC and Georgia Chapter of the.
Australian Commission on Safety and Quality in Health Care
Real-time control Model-Based Blood Glucose Control for Neonatal Intensive Care Engineering robust solutions for our most fragile infants Background and.
NRP 2006 – Western Canada Launch Vancouver, BC
MANAGEMENT FOR PAEDIATRIC PATIENT UNDER INVESTIGATION (PUI) WITH INFLUENZA-LIKE ILLNESS (ILI) IN OUTPATIENT SETTING CM CHOO HSAH 2013.
Rapid Response Team. What is a Rapid Response Team? A Rapid Response Team or RRT, is a working team of clinicians who bring critical care expertise to.
HYPOGLYCEMIA/ HYPERGLYCEMIA IN THE NEONATE What is the definition of a neonate? The first 30 days of an infants life or A premature infant that has not.
Neonatal Hypoglycemia Stan Jack, D.O. Saint Joseph Hospital Family Practice Residency.
Incorporating Preconception Health into MCH Services
 SC Guidelines for Diabetes Care Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.
1 Hospital Practices Influence Breastfeeding Rates: The Data Tell the Story Birth & Beyond California: Breastfeeding Training& QI Project.
Copyright © 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins The Normal Newborn Chapter 12.
Canadian Pediatric Society (CPS) Position Statement: Screening guidelines for newborns at risk for low blood glucose Dr. Hannah Weinstangel, PGY4 October.
But this is not the case every time HOW ? 3 IMPORTANT THINGS.
Sucrose in Neonates: Sources of Sweet Errors Pooja Shah, PharmD, BCPPS Clinical Assistant Professor Ernest Mario School of Pharmacy Rutgers University.
Neonatal hypoglycemia
CHILDREN and HIV.
Sarah M. Coors, DO1, PGY-6, Joseph L. Hagan, ScD1, Joshua J
EndoTool IV Physician User Guide Content Expert:
The vomiting child EMC SDMH 2015.
DIP, GDM; CLINICAL IMPORTANCE AND NEW WHO DIAGNOSTIC CRITERIA FOR GDM
Diabetic hypoglycemia from prevention to management.
Infant born with mother Tuberculosis
Infant clinical considerations
Neonatal Hypoglycemia
Case Study: Hypoglycemia/Sepsis Baby Boy Bobby Part I
Methotrexate in Psoriasis Shared Care Guidelines
Neonatal hypocalcemia
Nutrition Management of Maple Syrup Urine Disease
Protocol References Section Title 6.2 Entry Visit 5.1
Impending Delivery Skin-to-Skin in the Labor Room
Protocol References Section Title 6.2 Entry Visit 5.1
NEWBORN DEVELOPMENT RISK ASSESSMENT:
The Late Preterm Infant
NBN Hypoglycemia Protocol April 2010 Is the baby Symptomatic?
Continue 2-3 hour feedings
Post Partum.
Gestational Diabetes Lab 4.
Neonatal Nursing Care Neonatal Complications
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
WHO recommendations on interventions to improve preterm birth outcomes
Early Onset Sepsis: GBS
2015 Core Measures Perinatal Unit
Levine RA, DO. Miladinovic B, PhD. Nardell K, MD. Galas J, MD
Please mute yourselves, on phone or computer. Thank you.
Key Insulin Side Effects*
Continue 2-3 hour feedings
Management of At Risk Newborns for Hypoglycemia (First 24 Hrs of life)
Goals & Guidelines A summary of international guidelines for CHD
Obstetric Cholestasis (lntrahepatic cholestasis of pregnancy):
ROGER S. MAZZE, Ph.D., CHRISTOPHER L. KROGH, M.D. 
Presentation transcript:

SCREENING AND MANAGEMENT OF ASYMPTOMATIC NEWBORNS AT RISK FOR HYPOGLYCEMIA DURING FIRST 48 HRS OF LIFE “AT RISK”= SGA, LGA, IDM, Late PT (34 0/7  36 6/7 Birth GA), other clinical situations per physician discretion Bedside Glucose (BG): Screening is based on bedside glucose “BG” (whole blood glucose; typically 10-18% lower than plasma glucose) Throughout the algorithm, “feed” refers to maternal preference – breast feeding alone is considered sufficient if this is mother’s choice Assess for symptoms before every BG measurement and document in medical record. Contact Neonatal Provider immediately for symptomatic infants and administer one dose of OGG. Symptoms include: poor feeding, jitteriness, tremors, floppiness, lethargy, high pitched cry, irritability, grunting, cyanosis, apnea Oral Glucose Gel (OGG): dose is 0.5mL/kg  see reverse side for dosing chart Target glucose levels are > 35mg/dL from Birth  4 hrs, > 45 mg/dL from > 4  24 hrs, ≥ 50mg/dl from > 24-48 hours Begin feeding within 60 min of birth BG = 35-44 when between 4 and 24 hours of age Administer OGG immediately Place skin-to-skin and feed Repeat BG 1 hr after OGG dose Notify Neonatal Provider if > 24 hr of age BG screen #1 at 30 min after completion of first feed If >35: continue feeds q2-3hrs and perform pre-feed BG screen If <35: Administer OGG immediately Place skin-to-skin and feed Repeat BG 1 hr after OGG dose (not 1 hr after feed) BG >45 when between 4 and 24 hours of age OGG dose not needed Continue feeds q2-3hrs and perform pre-feed BG screen BG screen #2: Target > 35 (birth to 4 hrs) > 45 (4-24 hrs) If >Target Continue feeds q2-3hrs and perform pre-feed BG screen If <25: Notify Neonatal Provider and administer OGG If 25 to < Target: STOP WHEN: 4 consecutive values ( including post gel screen) in target range for age in hrs: Birth – 4 hr >35 > 4-24 hr >45 >24-48 hr ≥50 Administer OGG immediately Place skin-to-skin and feed Repeat BG 1 hr after OGG dose STOP Notify Neonatal Provider and give OGG immediately if: Infant is symptomatic Infant requires total THREE doses OGG since birth BG below the notification threshold (below): <25 at any time after the first OGG dose <35 from > 4 -24 hrs of age <50 at 24-48 hrs Continue feeds q 2-3 hrs with BG screens prior to feeds: If > Target: continue feeds q2-3hrs and perform pre-feed BG screen If <Target: administer OGG, place skin to skin and repeat BG in 1 hr Revised 6/21/2018

DISCLAIMER REGARDING CLINICAL PRACTICE GUIDELINES AND INDIVIDUAL PHYSICIAN/PATIENT DECISION-MAKING This clinical guideline provides reasonable thresholds for intervention; there is lack of consensus as to the actual definition of neonatal hypoglycemia, particularly during the first 24 hours of life. Infants with whole blood glucose values below 50 (between 24 and 48 hrs of age) or below 60 (at or beyond 48 hrs of age) may be at increased risk for inborn errors of metabolism or endocrine disorders . Close follow up is recommended, and consultation with a pediatric endocrinologist may be appropriate. Babies who do not reach a blood glucose of 60 by 48 hrs of age should be watched closely in the outpatient setting for signs and symptoms of metabolic conditions such as Congenital Hyperinsulinemia. These guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of newborns outside the Newborn Intensive Care Unit or Special Care Nursery with transitional neonatal hypoglycemia. They are not intended to either replace a clinician’s judgment or to establish a protocol for all patients with a particular condition. Some patients will not fit the clinical conditions contemplated by a guideline. Guidelines will rarely establish the only appropriate approach to a clinical problem. However, guidelines do represent an evidence-based and/or expert consensus regarding the clinical problem and reasons for deviating from the guideline should be apparent in the record. 40% ORAL GLUCOSE GEL DOSING CHART Recommended dose = 0.5mL/kg Birth Weight mL to administer < 2 kg 1 mL > 2 – 2.5 kg 1.25 mL > 2.5 – 3 kg 1.5 mL > 3 – 3.5 kg 1.75 mL > 3.5 – 4 kg 2 mL > 4 – 4.5 kg 2.25 mL > 4.5 – 5 kg 2.5 mL